These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 1748066

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Crucial role of aldose reductase activity and plasma glucose level in sorbitol accumulation in erythrocytes from diabetic patients.
    Hamada Y, Kitoh R, Raskin P.
    Diabetes; 1991 Oct; 40(10):1233-40. PubMed ID: 1936586
    [Abstract] [Full Text] [Related]

  • 4. Association of diabetic autonomic neuropathy with red blood cell aldose reductase activity.
    Gupta P, Verma N, Bhattacharya S, Mahdi AA, Usman K, Tiwari S, Bhardwaj K.
    Can J Diabetes; 2014 Feb; 38(1):22-5. PubMed ID: 24485209
    [Abstract] [Full Text] [Related]

  • 5. The effect of aldose reductase inhibition on erythrocyte polyols and galactitol accumulation in diabetic patients.
    Airey CM, Price DE, Kemp JV, Perkins CM, Wales JK.
    Diabet Med; 1989 Dec; 6(9):804-8. PubMed ID: 2533041
    [Abstract] [Full Text] [Related]

  • 6. Hyperglycemia-induced activation of human erythrocyte aldose reductase and alterations in kinetic properties.
    Srivastava SK, Ansari NH, Hair GA, Jaspan J, Rao MB, Das B.
    Biochim Biophys Acta; 1986 Mar 28; 870(2):302-11. PubMed ID: 3082363
    [Abstract] [Full Text] [Related]

  • 7. No correlation between glycemic control and an increase in erythrocyte aldose reductase activity in type I and type II diabetic patients.
    Hamada Y, Hammon K, Raskin P.
    J Diabetes Complications; 1992 Mar 28; 6(2):111-5. PubMed ID: 1611134
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of ageing on erythrocyte aldose reductase and sorbitol dehydrogenase activity.
    Funasako M, Fujimoto K, Taniji M, Suruda T, Nakai S, Kobayashi H, Sakagami Y, Ohata M.
    Mech Ageing Dev; 1994 Feb 28; 73(2):137-43. PubMed ID: 8051955
    [Abstract] [Full Text] [Related]

  • 11. Influence of interindividual variability of aldose reductase protein content on polyol-pathway metabolites and redox state in erythrocytes in diabetic patients.
    Hamada Y, Nishimura C, Koh N, Sakakibara F, Nakamura J, Tanimoto T, Hotta N.
    Diabetes Care; 1998 Jun 28; 21(6):1014-8. PubMed ID: 9614624
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of aldose reductase in human erythrocytes by vitamin C.
    Vincent TE, Mendiratta S, May JM.
    Diabetes Res Clin Pract; 1999 Jan 28; 43(1):1-8. PubMed ID: 10199583
    [Abstract] [Full Text] [Related]

  • 13. Correlation between erythrocyte aldose reductase activity and the width of skeletal-muscle capillary basement membrane in insulin-dependent diabetes mellitus.
    Hamada Y, Hammon K, Raskin P.
    J Diabetes Complications; 1992 Jan 28; 6(4):242-6. PubMed ID: 1482782
    [Abstract] [Full Text] [Related]

  • 14. Erythrocytic sorbitol contents in diabetic patients correlate with blood aldose reductase protein contents and plasma glucose levels, and are normalized by the potent aldose reductase inhibitor fidarestat (SNK-860).
    Asano T, Saito Y, Kawakami M, Yamada N, Sekino H, Hasegawa S, Fidarestat Clinical Pharmacology Study Group.
    J Diabetes Complications; 2004 Jan 28; 18(6):336-42. PubMed ID: 15531183
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Erythrocyte aldose reductase activity and sorbitol levels in diabetic retinopathy.
    Reddy GB, Satyanarayana A, Balakrishna N, Ayyagari R, Padma M, Viswanath K, Petrash JM.
    Mol Vis; 2008 Mar 24; 14():593-601. PubMed ID: 18385795
    [Abstract] [Full Text] [Related]

  • 18. The level of erythrocyte aldose reductase: a risk factor for diabetic neuropathy?
    Ito T, Nishimura C, Takahashi Y, Saito T, Omori Y.
    Diabetes Res Clin Pract; 1997 Jun 24; 36(3):161-7. PubMed ID: 9237782
    [Abstract] [Full Text] [Related]

  • 19. Activation of human erythrocyte, brain, aorta, muscle, and ocular tissue aldose reductase.
    Srivastava SK, Ansari NH, Hair GA, Awasthi S, Das B.
    Metabolism; 1986 Apr 24; 35(4 Suppl 1):114-8. PubMed ID: 3083202
    [Abstract] [Full Text] [Related]

  • 20. Purification and properties of aldose reductase and aldehyde reductase II from human erythrocyte.
    Das B, Srivastava SK.
    Arch Biochem Biophys; 1985 May 01; 238(2):670-9. PubMed ID: 3922304
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.